NCT02818907View on ClinicalTrials.gov

Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable

NACompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

May 19, 2016

Primary Completion Date

July 7, 2023

Study Completion Date

July 7, 2023

Conditions
Pancreatic Cancer
Interventions
OTHER

Additional biological samples

blood and tumor tissue samples

Trial Locations (8)

25000

Centre Hospitalier Régional Universitaire de Besançon, Besançon

Unknown

Centre Georges François Leclerc, Dijon

Centre Hospitalier Universitaire de Dijon, Dijon

Centre Hospitalier Universitaire de Nancy, Nancy

Institut de cancérologie de Lorraine, Nancy

Centre Hospitalier Universitaire Robert Debré, Reims

Centre Paul Strauss, Strasbourg

CHU de Strasbourg - Hautepierre, Strasbourg

All Listed Sponsors
collaborator

Cancéropôle Grand-Est

UNKNOWN

lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02818907 - Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable | Biotech Hunter | Biotech Hunter